Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study
Abstract:Summary
Background
Visceral leishmaniasis, also known on the Indian subcontinent as kala-azar, is a fatal form of leishmaniasis caused by the protozoan parasite
Leishmania donovani
and transmitted by the bites of the vector sandfly
Phlebotomus argentipes
. To achieve and sustain elimination of visceral leishmaniasis, the transmission potential of individuals exposed to
L donovani
from across the infection… Show more
“…PDKL, in particular, is considered the major interepidemic reservoir because such patients can have skin lesions for years without being systemically ill (Zijlstra et al, 2017). Recent studies of kalaazar and PKDL patients confirm historical data on their infectiousness (Molina et al, 2017;Mondal et al, 2019;Singh et al, 2021). Overall, 55.3% of enrolled PKDL patients had a positive direct xenodiagnosis result after sand flies fed on patients' lesions; the proportion was highest for those with nodular lesions but macular PKDL patients also infected sand flies at a substantial rate (Mondal et al, 2019).…”
Section: Reservoirs Of L Donovanimentioning
confidence: 89%
“…The model assumes that, in addition to VL and PKDL patients, asymptomatic carriers play a role in VL transmission, though with a much lower rate of infectiousness (Le Rutte et al, 2017). Studies that provide quantitative data needed to establish the potential of asymptomatic individuals as reservoirs for parasite transmission to vector populations are in progress (Singh et al, 2014;Tiwary et al, 2017;Singh et al, 2021). Non-human reservoir hosts have been sought but never proven to play a role in leishmanial transmission in the ISC (Singh et al, 2020).…”
Visceral leishmaniasis (VL) is a potentially deadly parasitic disease. In the Indian sub-continent, VL is caused by Leishmania donovani and transmitted via the bite of an infected Phlebotomus argentipes female sand fly, the only competent vector species in the region. The highest disease burden is in the northern part of the Indian sub-continent, especially in the state of Bihar. India, Bangladesh, and Nepal embarked on an initiative, coordinated by World Health Organization, to eliminate VL as a public health problem by the year 2020. The main goal is to reduce VL incidence below one case per 10,000 people through early case-detection, prompt diagnosis and treatment, and reduction of transmission using vector control measures. Indoor residual spraying, a major pillar of the elimination program, is the only vector control strategy used by the government of India. Though India is close to its VL elimination target, important aspects of vector bionomics and sand fly transmission dynamics are yet to be determined. To achieve sustained elimination and to prevent a resurgence of VL, knowledge gaps in vector biology and behavior, and the constraints they may pose to current vector control methods, need to be addressed. Herein, we discuss the successes and failures of previous and current vector-control strategies implemented to combat kala-azar in Bihar, India, and identify gaps in our understanding of vector transmission towards development of innovative tools to ensure sustained vector control in the post-elimination period.
“…PDKL, in particular, is considered the major interepidemic reservoir because such patients can have skin lesions for years without being systemically ill (Zijlstra et al, 2017). Recent studies of kalaazar and PKDL patients confirm historical data on their infectiousness (Molina et al, 2017;Mondal et al, 2019;Singh et al, 2021). Overall, 55.3% of enrolled PKDL patients had a positive direct xenodiagnosis result after sand flies fed on patients' lesions; the proportion was highest for those with nodular lesions but macular PKDL patients also infected sand flies at a substantial rate (Mondal et al, 2019).…”
Section: Reservoirs Of L Donovanimentioning
confidence: 89%
“…The model assumes that, in addition to VL and PKDL patients, asymptomatic carriers play a role in VL transmission, though with a much lower rate of infectiousness (Le Rutte et al, 2017). Studies that provide quantitative data needed to establish the potential of asymptomatic individuals as reservoirs for parasite transmission to vector populations are in progress (Singh et al, 2014;Tiwary et al, 2017;Singh et al, 2021). Non-human reservoir hosts have been sought but never proven to play a role in leishmanial transmission in the ISC (Singh et al, 2020).…”
Visceral leishmaniasis (VL) is a potentially deadly parasitic disease. In the Indian sub-continent, VL is caused by Leishmania donovani and transmitted via the bite of an infected Phlebotomus argentipes female sand fly, the only competent vector species in the region. The highest disease burden is in the northern part of the Indian sub-continent, especially in the state of Bihar. India, Bangladesh, and Nepal embarked on an initiative, coordinated by World Health Organization, to eliminate VL as a public health problem by the year 2020. The main goal is to reduce VL incidence below one case per 10,000 people through early case-detection, prompt diagnosis and treatment, and reduction of transmission using vector control measures. Indoor residual spraying, a major pillar of the elimination program, is the only vector control strategy used by the government of India. Though India is close to its VL elimination target, important aspects of vector bionomics and sand fly transmission dynamics are yet to be determined. To achieve sustained elimination and to prevent a resurgence of VL, knowledge gaps in vector biology and behavior, and the constraints they may pose to current vector control methods, need to be addressed. Herein, we discuss the successes and failures of previous and current vector-control strategies implemented to combat kala-azar in Bihar, India, and identify gaps in our understanding of vector transmission towards development of innovative tools to ensure sustained vector control in the post-elimination period.
“…rK39 ELISA was performed as described previously, using the same cut-off titer of ≥ 14 percentage point positivity (pp) to define a positive test as identified in the paper of Hasker et al (mean value for a healthy non-endemic control plus three standard deviations) (Hasker et al, 2013). Whole Blood Analysis (WBA) was performed as described elsewhere (Singh et al, 2021). In short, antigen-specific IFN-g levels produced in response to soluble Leishmania antigen (SLA) stimulation were determined by subtracting background levels measured in the non-stimulated samples.…”
Section: Laboratory Tests Leishmania Infection In Bloodmentioning
confidence: 99%
“…In short, antigen-specific IFN-g levels produced in response to soluble Leishmania antigen (SLA) stimulation were determined by subtracting background levels measured in the non-stimulated samples. The result was considered positive when the IFN-g concentration in the antigen wells was 52.28 pg/ml or higher (Singh et al, 2021).…”
Section: Laboratory Tests Leishmania Infection In Bloodmentioning
confidence: 99%
“…While the potential of diseased individuals to transmit Leishmania parasites to sand flies is firmly established (Swaminath et al, 1942;Costa et al, 2000;Vergel et al, 2006;Molina et al, 2017;Mondal et al, 2019), human xenodiagnosis studies have never been able to illustrate transmission from asymptomatic individuals -although it needs to be noted that the number of studies on this topic is limited (Costa et al, 2000;Singh et al, 2021). There are, however, some signs pointing in this direction, such as the presence of live L. donovani amastigotes in the blood of asymptomatically infected individuals in a VL endemic Indian village (Sharma et al, 2000).…”
BackgroundIn the endgame of the elimination initiative of visceral leishmaniasis (VL) on the Indian subcontinent, one of the main questions remaining is whether asymptomatically infected individuals also contribute to transmission. We piloted a minimally invasive microbiopsy device that could help answer this question. While the potential of this device has been previously illustrated in Ethiopia, no such information is available for the setting of the Indian subcontinent. In this proof of concept study we aimed to assess 1) to what extent skin parasite load obtained with the new microbiopsy device correlates with disease status, 2) to what extent skin parasite load correlates with blood parasite load in the same subject, and 3) to what extent the skin parasite load obtained from different sampling sites on the body correlates with one another.MethodsWe performed a pilot study in Bihar, India, including 29 VL patients, 28 PKDL patients, 94 asymptomatically infected individuals, 22 endemic controls (EC), and 28 non-endemic controls (NEC). Presence of infection with L. donovani in the blood was assessed using Direct Agglutination Test, rK39 ELISA, Whole Blood Analysis measuring IFN-γ and qPCR. A skin sample was collected with the microbiopsy device on two different locations on the body. PKDL patients provided a third skin sample from the edge of a PKDL lesion. Parasite load in the skin was measured by qPCR.FindingsWe found a clear correlation between the skin parasite load obtained with the microbiopsy device and disease status, with both higher skin parasite loads and higher proportions of positive skin samples in VL and PKDL patients compared to asymptomatics, EC, and NEC. No clear correlation between skin parasite load and blood parasite load was found, but a moderate correlation was present between the skin parasite load in arm and neck samples. In addition, we found four positive skin samples among asymptomatic individuals, and 85% of PKDL lesions tested positive using this microbiopsy device.ConclusionsIn line with previous pilot studies, our results from an Indian setting suggest that the microbiopsy device provides a promising tool to measure skin parasite load, and – if validated by xenodiagnosis studies – could facilitate much needed larger scale studies on infectiousness of human subgroups. In addition, we advocate further evaluation of this device as a diagnostic tool for PKDL.
Objectives
There is an urgent need to be able to identify individuals with asymptomatic Leishmania donovani infection, so their risk of progressing to VL and transmitting parasites can be managed. This study examined transcriptional markers expressed by CD4+ T cells that could distinguish asymptomatic individuals from endemic controls and visceral leishmaniasis (VL) patients.
Methods
CD4+ T cells were isolated from individuals with asymptomatic L. donovani infection, endemic controls and VL patients. RNA was extracted and RNAseq employed to identify differentially expressed genes. The expression of one gene and its protein product during asymptomatic infection were evaluated.
Results
Amphiregulin (AREG) was identified as a distinguishing gene product in CD4+ T cells from individuals with asymptomatic L. donovani infection, compared to VL patients and healthy endemic control individuals. AREG levels in plasma and antigen‐stimulated whole‐blood assay cell culture supernatants were significantly elevated in asymptomatic individuals, compared to endemic controls and VL patients. Regulatory T (Treg) cells were identified as an important source of AREG amongst CD4+ T‐cell subsets in asymptomatic individuals.
Conclusion
Increased Treg cell AREG expression was identified in individuals with asymptomatic L. donovani infection, suggesting the presence of an ongoing inflammatory response in these individuals required for controlling infection and that AREG may play an important role in preventing inflammation‐induced tissue damage and subsequent disease in asymptomatic individuals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.